Alyeska Investment Group, L.P. Taysha Gene Therapies, Inc. Transaction History

Alyeska Investment Group, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$20.3 - $31.75 $507,500 - $793,750	-25,000 Reduced 50.0%	25,000 $508,000
Q4 2020 Feb 16, 2021	SELL	$19.14 - $28.13 $7,656 - $11,252	-400 Reduced 0.79%	50,000 $1.33 Million
Q3 2020 Nov 16, 2020	BUY	$22.4 - $24.47 $1.13 Million - $1.23 Million	50,400 New	50,400 $1.13 Million

119

136M

25.9K

24K

Ticker TSHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,359,500
Market Cap $97.2M
Description
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.